A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

It works on the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor in the brain, and is used alongside a newly prescribed oral antidepressant. It works by restoring nerve cell ...

New York-based Forest Laboratories is testing Namenda (memantine), an Alzheimer's drug and N-methyl D-aspartate receptor (NMDA) receptor ... into a single meaningful pathway, he adds, “for ...

The startup's in-house projects include GM-1020, a small-molecule NMDA receptor channel blocker – the mechanism of action for ketamine – which is in phase 2a clinical development for major ...

Certain parts of the physiological processing of PrP or minor 'aberrent' pathways of PrP C biosynthesis and processing could result in potentially toxic species. There is, as of yet, no confirmed ...

Mental health treatment has evolved significantly over the years, offering new hope for individuals dealing with conditions ...

Saul persecuting Christians; Simon, the sorcerer; Philip and the Ethiopian. We make a serious mistake when we say that all our misfortunes and sufferings are caused by sin or Satan. We need to ...

Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, USA ...

Adenosine and various adenosine receptor ligands acting at adenosine A 1 and A 2A receptors have been explored in several experimental models of drug addiction. The therapeutic effects of the ...